| DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
HDAC4 |
HDAC4, KIAA0288: Histone deacetylase 4 |
2.345 |
Evidence |
|
| CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
2.345 |
Evidence |
|
| ERF |
ERF: ETS domain-containing transcription factor ERF |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
2.345 |
Evidence |
|
| IREB2 |
IREB2: Iron-responsive element-binding protein 2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.345 |
Evidence |
|
| SYK |
SYK: Tyrosine-protein kinase SYK |
IREB2 |
IREB2: Iron-responsive element-binding protein 2 |
2.345 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
DAPP1 |
IPI00004301 |
2.345 |
Evidence |
|
| CASP3 |
CASP3, CPP32: Caspase-3 precursor |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
2.345 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
IREB2 |
IREB2: Iron-responsive element-binding protein 2 |
2.345 |
Evidence |
|
| RGS2 |
RGS2, G0S8: Regulator of G-protein signaling 2 |
CRKL |
CRKL: Crk-like protein |
2.345 |
Evidence |
|
| CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
FZR1 |
IPI00099464 |
2.345 |
Evidence |
|
| MAPK4 |
MAPK4, ERK4, PRKM4: Mitogen-activated protein kinase 4 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
2.345 |
Evidence |
|
| APC |
IPI00215877 |
CHUK |
IPI00556043 |
2.345 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
AFF1 |
IPI00220068 |
2.345 |
Evidence |
|
| CMA1 |
CMA1, CYH, CYM: Chymase precursor |
MST1 |
IPI00555830 |
2.345 |
Evidence |
|
| IGFBP4 |
IGFBP4, IBP4: Insulin-like growth factor-binding protein 4 precursor |
ITIH2 |
IPI00619918 |
2.345 |
Evidence |
|
| ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
2.345 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
MNAR |
PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 |
2.345 |
Evidence |
|
| LIF |
LIF, HILDA: Leukemia inhibitory factor precursor |
TACSTD1 |
TACSTD1, GA733-2, M1S2, M4S1, MIC18, TROP1: Tumor-associated calcium signal tran |
2.345 |
Evidence |
|
| POU2F1 |
POU2F1, OCT1, OTF1: POU domain, class 2, transcription factor 1 |
H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
2.345 |
Evidence |
|
| EDN3 |
EDN3: Endothelin-3 precursor |
EDN2 |
EDN2: Endothelin-2 precursor |
2.345 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
PZP |
PZP: Pregnancy zone protein precursor |
2.345 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
HLA-DQB2 |
HLA-DQB2, DASS-256O6.1-002, XXbac-BCX231H22.1-002, XXbac-BPG3L13.3-002: Major hi |
2.345 |
Evidence |
|
| ASGR2 |
ASGR2: Asialoglycoprotein receptor 2 |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
2.345 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
SERPINA3 |
IPI00550991 |
2.345 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
ALB |
ALB: Uncharacterized protein ALB |
2.345 |
Evidence |
|